2007
DOI: 10.1080/01443610601062739
|View full text |Cite
|
Sign up to set email alerts
|

Use of erythropoietin in a pregnant Jehovah's Witness with sickle-cell disease

Abstract: 1999). There is a significantly increased prevalence of tinnitus in pregnant women compared with a similar non-pregnant group (Gurr et al. 1993).There are several speculations why tinnitus occurs in pregnancy. Hyperdynamic circulation, increase in perilymphatic fluid pressure and hormonal changes have been suggested (Preece et al. 1975).Tinnitus could be a warning sign of early pre-eclampsia (Shapiro et al. 1999). A rise in intracranial pressure (resulting from pre-eclampsia) can be transmitted to the perilymp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 4 publications
(2 reference statements)
1
5
0
Order By: Relevance
“…To ameliorate the potential anemia induced by HU, ESAs were considered. There was only one previous published report of EPO beta used in a pregnant SCD patient who was also a Jehovah's Witness and could not be transfused 27 . Her Hb was managed through pregnancy with ESAs and IV iron.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…To ameliorate the potential anemia induced by HU, ESAs were considered. There was only one previous published report of EPO beta used in a pregnant SCD patient who was also a Jehovah's Witness and could not be transfused 27 . Her Hb was managed through pregnancy with ESAs and IV iron.…”
Section: Discussionmentioning
confidence: 99%
“…There was only one previous published report of EPO beta used in a pregnant SCD patient who was also a Jehovah's Witness and could not be transfused. 27 Her Hb was managed through pregnancy with ESAs and IV iron. The pregnancy was successful, and the baby was small for gestational age.…”
Section: Medical Management Of Scd and Anemia In Pregnancymentioning
confidence: 99%
See 1 more Smart Citation
“…'s 14 observational study of Jehovah's Witnesses in the USA, all 166 women with low haematocrit at 28 weeks were offered erythropoietin but the 6 (4%) who accepted had a nonsignificant rise in haematocrit compared with those who declined. Erythropoietin cannot yet be recommended outside clinical trials because of limited data, but there are case reports describing its use in high‐risk Jehovah's Witness patients 25 …”
Section: Antenatal Managementmentioning
confidence: 99%
“…Erythropoietin has been shown to increase red cell production within days to weeks of use. 15 A combination of erythropoietin, iron supplementation, and hydroxyurea has been shown to increase fetal hemoglobin and ameliorate sickling crises. 16 Early aggressive intervention with these agents can sometimes prevent significant anemia and the ensuing complications.…”
Section: Response From Nnenna Ukachi Samantha Vanhorn Revathy Sundarammentioning
confidence: 99%